phenprocoumon has been researched along with Knee-Injuries* in 1 studies
1 other study(ies) available for phenprocoumon and Knee-Injuries
| Article | Year |
|---|---|
Thrombolysis of venous and arterial thrombosis by catheter-directed low-dose infusion of tissue plasminogen activator in children.
Thrombolytic therapy is a well-defined treatment option for arterial and venous thrombosis in adults. In contrast, uniform recommendations regarding the indication, route of administration, and dosing of thrombolytic therapy in children are not available. The authors report the successful resolution of bilateral pulmonary embolism and popliteal artery thrombosis in an 11-year-old girl and 13-year-old girl, respectively, by catheter-directed thrombolysis with low-dose recombinant tissue plasminogen activator. Catheter-directed low-dose thrombolysis is an efficient treatment option for severe venous and arterial thrombosis in children. Topics: Adolescent; Age Factors; Anticoagulants; Arthroscopy; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogens; Female; Fibrinolytic Agents; Hematoma; Heparin; Humans; Injections, Intra-Arterial; Knee Injuries; Lupus Erythematosus, Systemic; Phenprocoumon; Popliteal Artery; Postoperative Complications; Progesterone; Pulmonary Artery; Pulmonary Embolism; Recombinant Proteins; Sex Chromosome Disorders; Thrombolytic Therapy; Thrombophilia; Thrombosis; Tissue Plasminogen Activator; Trisomy | 2005 |